NCT06625931View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

March 28, 2025

Study Completion Date

March 28, 2025

Conditions
Parenteral Nutrition
Interventions
DRUG

NTCB01-1

3 Days infusion

DRUG

NTCB-P

3 Days infusion

Trial Locations (7)

16499

Ajou University Medical Center, Gyeonggi-do

42601

Keimyung University Dongsan Hospital, Daegu

49267

Kosin University Gospel Hospital, Busan

07061

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

03080

Seoul National University Hospital, Seoul

06591

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul

02841

Korea University Anam Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT06625931 - Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition | Biotech Hunter | Biotech Hunter